Stimulant Titration Week by Week: What Clinicians Track at Each ADHD Review
Introduction: Why Weekly Tracking Matters in Stimulant Titration
ADHD stimulant titration is not a one-off prescription—it is a structured, monitored process. During the first few weeks of treatment, clinicians track symptoms, side effects, and physical observations at each review to find the right dose for each individual.
Weekly tracking matters because it allows small, safe adjustments based on real-world response. It helps identify the “sweet spot” where ADHD symptoms are well controlled and side effects are minimal. For patients, this means better outcomes and greater confidence in treatment. For clinicians, it reduces risk and supports clear, defensible decision-making.
This guide walks through what clinicians typically track during stimulant titration, week by week, and what patients can expect at each review.
The First 4 Weeks: The Core Titration Phase
In UK practice, the first 2–4 weeks of stimulant titration are the most intensive. NICE-aligned pathways recommend weekly contact during this phase, either in person, by video, or by telephone, to assess response and adjust doses safely.
Week 1: Baseline and Tolerance Check
Goals:
Confirm the person is tolerating the starting dose
Identify any immediate side effects
Establish a baseline for symptom and functional change
What Clinicians Track:
Current dose and timing: exact medication, dose, and what time it is taken
ADHD symptoms: early changes in focus, impulsivity, organisation, and emotional regulation
Side effects: appetite, sleep onset, headaches, dry mouth, nausea, jitteriness, mood changes
Vital signs: blood pressure and pulse (especially if not recently recorded)
Weight: baseline weight for future comparison
Functioning: any early changes in work, study, or daily routines
Typical Decisions:
Continue same dose if well tolerated
Reduce dose if side effects are significant
Plan next dose increase if response is partial and tolerability is good
Patients are often asked to keep a simple daily log of dose time, focus, side effects, and sleep during this week.
Week 2: Early Response and First Dose Adjustment
Goals:
Assess whether the starting dose is having a meaningful effect
Decide whether to increase, maintain, or adjust the dose
Monitor early side effect patterns
What Clinicians Track:
Symptom change: is there noticeable improvement in attention, task initiation, or impulse control?
Duration of effect: how many hours does the medication seem to work? Is there a “crash” as it wears off?
Side effects: appetite suppression, insomnia, irritability, anxiety, palpitations, headaches
Vital signs: blood pressure and pulse compared to baseline
Weight: any early weight change, especially if appetite is reduced
Sleep: time to fall asleep, total sleep hours, sleep quality
Mood and emotional regulation: any increase in irritability, emotional flatness, or anxiety
Typical Decisions:
Increase dose if response is partial and side effects are mild
Maintain dose if response is good and side effects are emerging
Reduce dose or change formulation if side effects are problematic
Standardised rating scales (e.g., ASRS for adults, parent/teacher scales for children) may be repeated at this stage to quantify change.
Week 3: Optimising Dose and Refining Timing
Goals:
Move closer to the optimal dose
Refine dosing time or formulation if needed
Ensure side effects remain manageable
What Clinicians Track:
Symptom control: is focus more consistent? Is impulsivity better managed?
Functional outcomes: improvements in work output, study completion, household tasks, or relationships
Side effect trajectory: are early side effects settling, worsening, or new ones appearing?
Appetite and nutrition: ability to eat regular meals, any significant weight change
Sleep: ongoing monitoring of sleep onset and quality
Vital signs: blood pressure and pulse trends over time
Rebound or “crash”: late-day irritability, fatigue, or low mood as medication wears off
Typical Decisions:
Further dose increase if response is still suboptimal and tolerability is good
Adjust timing (e.g., earlier dose, different formulation) if sleep or appetite is affected
Consider switching medication if side effects persist or response is inadequate
By week 3, many patients begin to see clearer patterns in how the medication affects their day.
Week 4: Approaching Stabilisation
Goals:
Determine whether the current dose is close to optimal
Decide whether to continue titrating or begin stabilisation
Plan ongoing monitoring and follow-up
What Clinicians Track:
Overall symptom improvement: compared to baseline and week 1
Side effect burden: are side effects mild, moderate, or limiting daily life?
Functional gains: tangible improvements in work, study, home life, and relationships
Vital signs: blood pressure and pulse within acceptable ranges
Weight and appetite: stable or manageable changes
Sleep: sustainable sleep pattern without significant disruption
Patient preference: does the patient feel the benefits outweigh the downsides?
Typical Decisions:
Maintain current dose and move toward stabilisation if response is good
Make one final small dose adjustment if near-optimal but not quite there
Consider switching medication if response is inadequate or side effects are unacceptable
At this point, many clinicians begin discussing longer-term monitoring and, if appropriate, shared care with the GP.
Beyond Week 4: Stabilisation and Maintenance
Once a stable, effective dose is reached, the focus shifts to maintenance and ongoing monitoring.
Weeks 5–8: Consolidation
Reviews may move to every 2–4 weeks
Focus on sustaining gains and managing any emerging issues
Monitor weight, appetite, sleep, mood, and vital signs
Address any comorbidities (e.g., anxiety, depression) that may need parallel support
Months 3–6: Long-Term Monitoring
Reviews typically every 3–6 months once stable
Ongoing checks of blood pressure, pulse, and weight
Assessment of continued symptom control and functioning
Review of any new life stressors, medication changes, or side effects
Annual Review
Comprehensive review of diagnosis, treatment, and outcomes
Physical health monitoring (BP, pulse, weight, cardiovascular risk)
Discussion of ongoing need for medication and any plans to adjust or pause treatment
What Patients Can Do to Support Weekly Tracking
Patients can make titration more effective by keeping simple, honest records between reviews.
Keep a Daily Log
Track:
Dose time and amount
Focus and productivity through the day
Side effects (appetite, sleep, mood, physical symptoms)
Sleep hours and quality
Even brief notes are helpful. Consistency matters more than detail.
Prepare for Each Review
Before each appointment:
Review your notes and identify key changes
List any questions or concerns
Note any major life changes or stressors
Being organised saves time and improves the quality of each review.
Communicate Honestly
If something feels wrong—whether it is side effects, mood changes, or lack of benefit—tell your clinician. Titration is a partnership, and your feedback is essential.
FAQs: Stimulant Titration Week by Week
How often are reviews during stimulant titration?
During the first 2–4 weeks, weekly contact is recommended. After that, reviews occur at least monthly until symptoms are fully stabilised.
What do clinicians check at each titration review?
Clinicians track ADHD symptoms, side effects, blood pressure, pulse, weight, sleep, appetite, mood, and functional changes at work, school, and home.
How long does the weekly titration phase last?
The intensive weekly phase typically lasts 2–4 weeks, followed by monthly reviews until a stable dose is reached.
What if I have significant side effects during titration?
Tell your clinician promptly. Dose reductions, timing adjustments, or medication changes can often resolve side effects.
Do I need to keep a daily log during titration?
It is highly recommended. Simple notes on dose time, focus, side effects, and sleep help your clinician make better decisions.
Can titration be done remotely?
Yes. Many services offer remote titration with video or telephone reviews, as long as safety checks and monitoring are in place.
What happens after the first 4 weeks of titration?
If response is good, you move toward stabilisation with less frequent reviews. If not, your clinician may adjust the dose or consider a different medication.
Book Your ADHD Assessment Today
If you are struggling with focus, organisation, impulsivity, or emotional regulation, you do not have to navigate it alone. A thorough ADHD assessment is the first step toward understanding your symptoms and exploring treatment options, including safe, supported stimulant titration.
At Focus Gently, we are committed to clear, compassionate, and evidence-based ADHD care. From assessment through titration and ongoing support, our goal is to help you move forward with confidence.
Ready to take the next step?
Book your ADHD assessment today at https://www.focusgently.com/ and start your journey toward clearer focus, better organisation, and greater control over your day.
